Charm Engineering참엔지니어링
009310 · KOSPI · ₩009310 · 참엔지니어링
- Market cap
- ₩23B
- Enterprise value
- −₩104B
- P/E
- —
- P/B
- 0.3×
- Dividend yield
- 0.0%
- ROE
- −7.1%
- Net margin
- −6.7%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−37.5% from the high
₩4,324Today: ₩5,330 – ₩5,330₩8,533
Returns
- 1W0.0%
- 1M0.0%
- 3M0.0%
- 6M0.0%
- YTD−3.7%
- 1Y−16.0%
- Volume today
- —
- Traded today
- —
- Listed shares
- 4,377,014
- EPS (12 months)
- −₩1,342
- Earnings yield −25.2%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumFlat0% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Charm Engineering stock overview
Charm Engineering (참엔지니어링, KRX: 009310) is listed on KOSPI, in the Machinery sector. , Ltd. Its shares closed at ₩5,330 on Oct 27, 2026, unchanged on the day, giving it a market value of ₩23B.
Key facts
- Market cap
- ₩23B
- Sector
- Machinery
- Latest price change
- 0.00%
- As of
- Oct 27, 2026
- Main business
- , Ltd.
Quick answers about Charm Engineering
- What does Charm Engineering do?
- , Ltd. and its subsidiaries operate in engineering businesses, including display equipment manufacturing and related maintenance and after-sales services. The company has stopped accepting new display equipment orders and is winding down that business, while also holding loan receivables and financial assets as part of its operations.
- What is the market cap of Charm Engineering?
- The market capitalisation of Charm Engineering was ₩23B at the close on Oct 27, 2026.
- Who are the largest shareholders of Charm Engineering?
- According to the latest official filings, the largest reported holders are HB Holdings Group (60.82%, as of Apr 13, 2026); HBC New Technology Investment Partnership No. 1 (14.62%, as of Apr 13, 2026); National Pension Service (0.11%, as of Dec 31, 2022).
- When is the next earnings report from Charm Engineering?
- Korean companies rarely announce results dates in advance. Based on when Charm Engineering filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Charm Engineering?
- Yes. The National Pension Service held 0.11% of Charm Engineering shares as of Dec 31, 2022.
Company profile
Chamen Engineering Co., Ltd. and its subsidiaries operate in engineering businesses, including display equipment manufacturing and related maintenance and after-sales services. The company has stopped accepting new display equipment orders and is winding down that business, while also holding loan receivables and financial assets as part of its operations. Its consolidated financial statements cover the 2025 and 2024 fiscal years.
Written by AI from the company's latest annual report.
- Korean name
- 참엔지니어링
- Sector
- Machinery
- CEO
- 안경환
- Founded
- Oct 1973
- Listed
- Nov 1987
- Listed shares
- 4,377,014
- Fiscal year ends
- Month 12
- Website
- www.charmeng.com
Similar companies
- Doosan Enerbility034020 · ₩38T₩58,900+2.26%
- Hanmi Semiconductor042700 · ₩18T₩191,400+4.02%
- Jusung Engineering036930 · ₩8.1T₩174,800+4.30%
- Rainbow Robotics277810 · ₩6.8T₩351,500+1.15%
- EO Technics039030 · ₩4.9T₩395,000+4.22%
- Doosan Bobcat241560 · ₩4.7T₩48,650+0.21%
- Wonik IPS240810 · ₩4.6T₩93,800+4.92%
- HD Construction Equipment267270 · ₩3.8T₩80,800−0.25%
Recent filings
See all- Amended: Major sales or supply contractOct 21, 2026
- Amended: Half-year report (Jun 2026)Oct 8, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- Other management mattersJul 16, 2026
- DelistingJul 15, 2026
Titles in Korean until English translations are added.
Also known as: Charm Engineering / 참엔지니어링 / 009310 / KRX:009310
Source: KRX statistical information